Patient Advisory Boards in Belgium: Turning Patient Insight into Strategic Healthcare Impact

In today’s pharmaceutical landscape, patient-centricity is no longer a slogan. It is an operational requirement.

Health authorities, payers and healthcare professionals increasingly expect companies to demonstrate that patients are involved in the development of treatments, services and support programs.

One of the most effective ways to do this is through Patient Advisory Boards.

When structured correctly, a Patient Advisory Board provides direct insights from people living with a disease. These insights can shape clinical development, improve patient support programs and strengthen market access strategies.

Yet in Belgium, organizing a meaningful Patient Advisory Board is often far more complex than it appears.

From limited patient populations to compliance constraints and multilingual realities, many pharmaceutical teams struggle to transform the idea of patient engagement into a structured and compliant initiative.

This is where specialized support becomes essential.

Pharmaceutical teams spend years developing treatments.
But only patients truly understand what living with a disease means on a daily basis.

Patient Advisory Boards allow companies to explore questions that clinical data alone cannot answer.

For example:

• How does the disease affect daily routines and quality of life?
• What are the real barriers to treatment adherence?
• What support would genuinely help patients and caregivers?
• How understandable are educational materials and communication tools?

These insights can influence multiple strategic areas:

• Clinical trial design
• Patient support programs
• Treatment adherence initiatives
• Market access strategy
• Patient education materials

In many cases, Patient Advisory Boards also help teams identify unmet needs that were not visible from a purely clinical perspective.

The result is a more relevant, patient-centered healthcare strategy.

Belgium offers a highly sophisticated healthcare ecosystem and strong clinical expertise.

However, when it comes to patient engagement initiatives, the country presents several operational challenges.

Belgium’s population is relatively small.

For rare diseases or highly specialized therapeutic areas, identifying a representative group of patients can already be a challenge.

Recruitment often requires:

• Collaboration with patient organizations
• Careful screening of candidates
• Geographic coordination across regions.

Without a structured network, the recruitment phase alone can take months.

Belgium operates across three main languages:

• Dutch
• French
• English (often used in international discussions)

For Patient Advisory Boards, this creates additional complexity.

Patients must feel comfortable expressing their experiences in their native language.
At the same time, pharmaceutical teams require structured outputs that can be shared internally across international teams.

This often means:

• Multilingual moderation
• Translated discussion guides
• Simultaneous interpretation during sessions
• Multilingual reporting

Without careful planning, language barriers can significantly reduce the quality of insights.

Patient engagement activities in Belgium must comply with strict ethical and regulatory frameworks.

Industry interactions with patients and patient organizations must follow transparency and ethical collaboration principles defined by national and European codes.

Key compliance elements include:

• Fair Market Value compensation
• Transparent agreements and contracts
• Clear advisory purpose (non-promotional)
• Documentation and reporting of interactions

Many internal teams underestimate the amount of preparation required to ensure compliance.

Patients participating in advisory boards often have very different levels of medical knowledge.

Some may be deeply involved in advocacy groups.
Others may have little experience interacting with pharmaceutical companies.

This means that discussion guides, moderation and facilitation must be carefully designed to ensure that all participants can contribute meaningfully.

Without proper preparation, the meeting risks becoming either too technical or too superficial.

At Novellas Healthcare, we specialize in transforming complex patient engagement initiatives into structured, compliant and impactful projects.

Our approach combines strategic thinking, operational execution and local expertise in the Belgian healthcare ecosystem.

Every Patient Advisory Board begins with a clear strategic objective.

We help teams define:

• The key questions to explore
• The patient profiles required
• The expected outcomes
• How insights will influence internal decision-making

This ensures the advisory board produces actionable results rather than general discussions.

Through our network of patient organizations, healthcare professionals and community contacts, we help identify patients who can bring meaningful perspectives.

Our recruitment process includes patient identification, outreach, eligibility screening and logistical coordination.

This significantly reduces the time required to assemble a high-quality patient panel.

Ensuring full compliance is a critical component of any Patient Advisory Board in Belgium. Interactions between pharmaceutical companies and patients must follow strict ethical and regulatory frameworks, requiring clear transparency, appropriate compensation and well-documented collaboration agreements.

Novellas Healthcare manages the entire compliance process to ensure that every advisory board is conducted according to Belgian and European standards. This includes preparing contractual agreements, validating fair market value compensation and ensuring that all interactions remain strictly non-promotional and aligned with regulatory expectations.

By handling these elements from the start of the project, we allow pharmaceutical teams to focus on what truly matters: listening to patients and translating their experiences into meaningful strategic insights.

A successful Patient Advisory Board requires more than gathering patients in a room. The quality of the discussion depends heavily on how the conversation is guided and how comfortable participants feel sharing their experiences.

At Novellas Healthcare, our facilitators create an environment where patients feel heard and respected while ensuring that discussions remain structured and aligned with the objectives of the advisory board. Because Belgium is a multilingual country, we also ensure that language never becomes a barrier to meaningful participation, supporting discussions through multilingual moderation and interpretation when needed.

This approach helps transform patient conversations into clear, actionable insights that can inform medical, patient engagement and market access strategies.

The real value of a Patient Advisory Board emerges after the discussion has taken place. Patient experiences and perspectives must be translated into structured insights that can support strategic decision-making within pharmaceutical organizations.

Novellas Healthcare analyzes the discussions, identifies key themes and translates patient feedback into clear strategic recommendations. These insights often reveal gaps in patient support, opportunities to improve adherence or ways to better address unmet needs throughout the patient journey.

By transforming qualitative patient conversations into actionable outputs, Patient Advisory Boards become a powerful tool to guide patient-centric healthcare strategies.

Patient Advisory Boards are particularly valuable during key moments in the lifecycle of a therapy.

For example:

Pre-launch
To understand patient expectations and refine support strategies

Clinical development
To improve study design and patient recruitment strategies

Patient support programs
To co-create meaningful services that improve adherence

Rare diseases
To understand daily challenges that clinical teams may overlook

In many cases, involving patients earlier in the development process significantly improves long-term outcomes.

Pharmaceutical innovation is not only about developing new treatments.

It is also about understanding the real experiences of the people those treatments are meant to help.

Patient Advisory Boards create a structured way to bring those voices into strategic decision-making.

When executed properly, they do more than generate insights.

They build trust between industry, patients and healthcare systems.

Planning a Patient Advisory Board in Belgium?

Whether you are exploring a rare disease initiative, a patient support program or a pre-launch strategy, our team can help you design and execute a compliant, impactful advisory board.

👉 Start the conversation with our team.
Use the form below to brainstorm your upcoming Patient Advisory Board project with Novellas Healthcare.